Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
Edesa Biotech reports 2021 executive compensation
By ExecPay News
Published: April 1, 2022
Edesa Biotech reported fiscal year 2021 executive compensation information on April 1, 2022.
In 2021, three executives at Edesa Biotech received on average a compensation package of $1.1M, a 136% increase compared to previous year.
Average pay of disclosed executives at Edesa Biotech
Pardeep Nijhawan, Chief Executive Officer, received $1.3M in total, which increased by 221% compared to 2020. 62% of Nijhawan's compensation, or $821K, was in option awards. Nijhawan also received $120K in bonus, $315K in salary, as well as $64K in other compensation.
Michael Brooks, President, received a compensation package of $1.1M, which increased by 99% compared to previous year. 58% of the compensation package, or $606K, was in option awards.
Kathi Niffenegger, Chief Financial Officer, earned $1M in 2021, a 106% increase compared to previous year.
Edesa Biotech's fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on April 1, 2022.